1

Sildenafil and Big Pharma: A Risky Bet?

News Discuss 
The story of Viagra presents a challenging picture for investors. While the initial launch generated substantial returns, the end of its exclusive rights opened the avenue to cheaper versions, dramatically eroding https://www.idgod.com

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story